Warning letter
Henan Lvyuan Pharmaceutical Co. Ltd.: warning letter of Mar 26, 2026
FDA warning letter 722497 · Center for Veterinary Medicine
Key facts
| Reference number | 722497 |
|---|---|
| Company | Henan Lvyuan Pharmaceutical Co. Ltd. |
| Subject | CGMP/API/Adulterated |
| Issue date | Mar 26, 2026 |
| Posted date | Mar 31, 2026 |
| Issuing office | Center for Veterinary Medicine |
| Product type | Drugs |
| Inspection city | Xinxiang |
| Inspection start date | Sep 22, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: